91 related articles for article (PubMed ID: 26855992)
41. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
[TBL] [Abstract][Full Text] [Related]
42. Differential BCCIP gene expression in primary human ovarian cancer, renal cell carcinoma and colorectal cancer tissues.
Liu X; Cao L; Ni J; Liu N; Zhao X; Wang Y; Zhu L; Wang L; Wang J; Yue Y; Cai Y; Jin J
Int J Oncol; 2013 Dec; 43(6):1925-34. PubMed ID: 24101097
[TBL] [Abstract][Full Text] [Related]
43. PKA RIα/A-kinase anchoring proteins 10 signaling pathway and the prognosis of colorectal cancer.
Wang M; Li Y; Wang R; Wang Z; Chen K; Zhou B; Zhou Z; Sun X
J Gastroenterol Hepatol; 2015 Mar; 30(3):496-503. PubMed ID: 25213315
[TBL] [Abstract][Full Text] [Related]
44. MiR-199a-5p is negatively associated with malignancies and regulates glycolysis and lactate production by targeting hexokinase 2 in liver cancer.
Guo W; Qiu Z; Wang Z; Wang Q; Tan N; Chen T; Chen Z; Huang S; Gu J; Li J; Yao M; Zhao Y; He X
Hepatology; 2015 Oct; 62(4):1132-44. PubMed ID: 26054020
[TBL] [Abstract][Full Text] [Related]
45. Overexpression of the nonpancreatic secretory group II PLA2 messenger RNA and protein in colorectal adenomas from familial adenomatous polyposis patients.
Kennedy BP; Soravia C; Moffat J; Xia L; Hiruki T; Collins S; Gallinger S; Bapat B
Cancer Res; 1998 Feb; 58(3):500-3. PubMed ID: 9458096
[TBL] [Abstract][Full Text] [Related]
46. Glycolysis back in the limelight: systemic targeting of HK2 blocks tumor growth.
Ros S; Schulze A
Cancer Discov; 2013 Oct; 3(10):1105-7. PubMed ID: 24124231
[TBL] [Abstract][Full Text] [Related]
47. Upregulated expression of angiogenesis genes and down regulation of cell cycle genes in human colorectal cancer tissue determined by cDNA macroarray.
Tsunoda T; Nakamura T; Ishimoto K; Yamaue H; Tanimura H; Saijo N; Nishio K
Anticancer Res; 2001; 21(1A):137-43. PubMed ID: 11299727
[TBL] [Abstract][Full Text] [Related]
48. Down-regulation of PIK3CG, a catalytic subunit of phosphatidylinositol 3-OH kinase, by CpG hypermethylation in human colorectal carcinoma.
Semba S; Itoh N; Ito M; Youssef EM; Harada M; Moriya T; Kimura W; Yamakawa M
Clin Cancer Res; 2002 Dec; 8(12):3824-31. PubMed ID: 12473596
[TBL] [Abstract][Full Text] [Related]
49. miR-106a overexpression and pRB downregulation in sporadic colorectal cancer.
Catela Ivkovic T; Aralica G; Cacev T; Loncar B; Kapitanovic S
Exp Mol Pathol; 2013 Feb; 94(1):148-54. PubMed ID: 23178825
[TBL] [Abstract][Full Text] [Related]
50. PI3K/Akt signaling mediated Hexokinase-2 expression inhibits cell apoptosis and promotes tumor growth in pediatric osteosarcoma.
Zhuo B; Li Y; Li Z; Qin H; Sun Q; Zhang F; Shen Y; Shi Y; Wang R
Biochem Biophys Res Commun; 2015 Aug; 464(2):401-6. PubMed ID: 26116768
[TBL] [Abstract][Full Text] [Related]
51. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
52. Expression and effect of CXCL14 in colorectal carcinoma.
Lin K; Zou R; Lin F; Zheng S; Shen X; Xue X
Mol Med Rep; 2014 Sep; 10(3):1561-8. PubMed ID: 24938992
[TBL] [Abstract][Full Text] [Related]
53. Mitotic kinase expression and colorectal cancer progression.
Katayama H; Ota T; Jisaki F; Ueda Y; Tanaka T; Odashima S; Suzuki F; Terada Y; Tatsuka M
J Natl Cancer Inst; 1999 Jul; 91(13):1160-2. PubMed ID: 10393726
[No Abstract] [Full Text] [Related]
54. Hexokinases 2 promoted cell motility and distant metastasis by elevating fibronectin through Akt1/p-Akt1 in cervical cancer cells.
Chen Q; Li L; Liu X; Feng Q; Zhang Y; Zheng P; Cui N
Cancer Cell Int; 2021 Nov; 21(1):600. PubMed ID: 34758823
[TBL] [Abstract][Full Text] [Related]
55. Discovery of a Novel 2,6-Disubstituted Glucosamine Series of Potent and Selective Hexokinase 2 Inhibitors.
Lin H; Zeng J; Xie R; Schulz MJ; Tedesco R; Qu J; Erhard KF; Mack JF; Raha K; Rendina AR; Szewczuk LM; Kratz PM; Jurewicz AJ; Cecconie T; Martens S; McDevitt PJ; Martin JD; Chen SB; Jiang Y; Nickels L; Schwartz BJ; Smallwood A; Zhao B; Campobasso N; Qian Y; Briand J; Rominger CM; Oleykowski C; Hardwicke MA; Luengo JI
ACS Med Chem Lett; 2016 Mar; 7(3):217-22. PubMed ID: 26985301
[TBL] [Abstract][Full Text] [Related]
56. Comprehensive bioinformatics analysis of the characterization and determination underlying mechanisms of over-expression and co-expression of genes residing on 20q in colorectal cancer.
Li D; Lin C; Chen M; Li N; Du Y; Su C; Yang C; Gong N; Wu H; Wu R; Jain A; Zhang Y; Li X
Oncotarget; 2017 Oct; 8(45):78642-78659. PubMed ID: 29108255
[TBL] [Abstract][Full Text] [Related]
57. Hexokinases in cancer and other pathologies.
Guo D; Meng Y; Jiang X; Lu Z
Cell Insight; 2023 Feb; 2(1):100077. PubMed ID: 37192912
[TBL] [Abstract][Full Text] [Related]
58. HK3 is correlated with immune infiltrates and predicts response to immunotherapy in non-small cell lung cancer.
Tuo Z; Zheng X; Zong Y; Li J; Zou C; Lv Y; Liu J
Clin Transl Med; 2020 Jan; 10(1):319-330. PubMed ID: 32508023
[TBL] [Abstract][Full Text] [Related]
59. The Crosstalk Between Signaling Pathways and Cancer Metabolism in Colorectal Cancer.
Hon KW; Zainal Abidin SA; Othman I; Naidu R
Front Pharmacol; 2021; 12():768861. PubMed ID: 34887764
[TBL] [Abstract][Full Text] [Related]
60. Hexokinase 3 dysfunction promotes tumorigenesis and immune escape by upregulating monocyte/macrophage infiltration into the clear cell renal cell carcinoma microenvironment.
Xu W; Liu WR; Xu Y; Tian X; Anwaier A; Su JQ; Zhu WK; Shi GH; Wei GM; Huang YP; Qu YY; Zhang HL; Ye DW
Int J Biol Sci; 2021; 17(9):2205-2222. PubMed ID: 34239350
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
